Cara Therapeutics reported $184.82M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Acelrx Pharmaceuticals ACRX:US USD 27.54M 5.6M
Aerie Pharmaceuticals AERI:US USD -163982000 22.85M
Cara Therapeutics CARA:US USD 184.82M 19.6M
Chugai Pharma 4519:JP JPY 1.31T 1.29B
Depomed DEPO:US USD 134.92M 6.55M
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Pacira Pharmaceuticals PCRX:US USD 770.12M 13.49M
Pain Therapeutics PTIE:US USD 198.72M 19.65M
Revance Therapeutics RVNC:US USD 145.71M 148.34M
Supernus Pharmaceuticals SUPN:US USD 852.8M 11.36M
Teva Pharmaceutical Industries TEVA:US USD 8.77B 269M
Vanda Pharmaceuticals VNDA:US USD 515.66M 7.11M